GS vs OCGN · P/E 20, rev $58.28B vs rev $3.0M
Goldman Sachs Group Inc (GS) versus Ocugen Inc (OCGN) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Ocugen Inc (OCGN) is a biotechnology company listed on NASDAQ.
Latest reported GS revenue for 2025-12-31 was $58.28B. Net income was $17.18B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Latest reported OCGN revenue for 2026-06-30 was $3.0M. Net income was -$44.1M. Revenue was up 97.1% from 2026-03-31 to 2026-06-30. OCGN currently screens at market cap $416.4M.
GS currently screens at market cap $324.25B and trailing P/E 20.1. OCGN currently screens at market cap $416.4M.
Not investment advice. Open the GS and OCGN stock pages for the full models.
Not investment advice.